Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4+ subset and oligoclonal in the CD8+ subset

Experimental Hematology

Volumn 37, Issue 8, 2009, Pages 947-955

  Fozza, Claudio ^a   Contini, Salvatore ^a   Galleu, Antonio ^a   Simula, Maria Pina ^a   Virdis, Patrizia ^a   Bonfigli, Silvana ^a   Longinotti, Maurizio ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; LYMPHOCYTE PROLIFERATION; MALE; MYELODYSPLASTIC SYNDROME; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 67650065350     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.04.009     Document Type: Article

References (34)

1. Bacher U., Haferlach T., Kern W., Haferlach C., and Schnittger S. A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia. Haematologica 92 (2007) 744-752
2. Billstrom R., Johansson H., Johansson B., and Mitelman F. Immune-mediated complications in patients with myelodysplastic syndromes-clinical and cytogenetic features. Eur J Haematol 55 (1995) 42-48
3. Killick S.B., Mufti G., Cavenagh J.D., et al. A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia. Br J Haematol 120 (2003) 679-684
4. Molldrem J.J., Caples M., Mavroudis D., Plante M., Young N.S., and Barrett A.J. Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol 99 (1997) 699-705
5. Okamoto T., Okada M., Mori A., et al. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol 66 (1997) 345-351
6. Voulgarelis M., Giannouli S., Ritis K., and Tzioufas A.G. Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest 34 (2004) 690-700
7. Castro M., Conn D.L., Su W.P., and Garton J.P. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 18 (1991) 721-727
8. Giannouli S., Voulgarelis M., Zintzaras E., Tzioufas A.G., and Moutsopoulos H.M. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology (Oxford) 43 (2004) 626-632
9. Kordasti S.Y., Ingram W., Hayden J., et al. CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood 110 (2007) 847-850
10. Molldrem J.J., Jiang Y.Z., Stetler-Stevenson M., Mavroudis D., Hensel N., and Barrett A.J. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. Br J Haematol 102 (1998) 1314-1322
11. Smith M.A., and Smith J.G. The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: an in vitro study. Leuk Res 15 (1991) 597-601
12. Langerak A.W., van Den Beemd R., Wolvers-Tettero I.L., Boor P.P., van Lochem E.G., Hooijkaas H., and van Dongen J.J. Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood 98 (2001) 165-173
13. Gorski J., Yassai M., Zhu X., Kissela B., Kissella B., Keever C., and Flomenberg N. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 152 (1994) 5109-5119
14. Melenhorst J.J., Eniafe R., Follmann D., Nakamura R., Kirby M., and Barrett A.J. Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome. Br J Haematol 119 (2002) 97-105
15. Epperson D.E., Nakamura R., Saunthararajah Y., Melenhorst J., and Barrett A.J. Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process. Leuk Res 25 (2001) 1075-1083
16. Matsutani T., Yoshioka T., Tsuruta Y., et al. Determination of T-cell receptors of clonal CD8-positive T-cells in myelodysplastic syndrome with erythroid hypoplasia. Leuk Res 27 (2003) 305-312
17. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
18. Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
19. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
20. Chen X., Barfield R., Benaim E., et al. Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. Blood 105 (2005) 886-893
21. Lu J., Basu A., Melenhorst J.J., Young N.S., and Brown K.E. Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood 103 (2004) 4588-4593
22. Bonfigli S., Doro M.G., Fozza C., Derudas D., Dore F., and Longinotti M. T-cell receptor repertoire in healthy Sardinian subjects. Hum Immunol 64 (2003) 689-695
23. Ricalton N.S., Roberton C., Norris J.M., Rewers M., Hamman R.F., and Kotzin B.L. Prevalence of CD8+ T-cell expansions in relation to age in healthy individuals. J Gerontol A Biol Sci Med Sci 53 (1998) B196-B203
24. Wlodarski M.W., Gondek L.P., Nearman Z.P., et al. Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome. Blood 108 (2006) 2632-2641
25. Epling-Burnette P.K., Painter J.S., Rollison D.E., et al. Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome. Leukemia 21 (2007) 659-667
26. Risitano A.M., Kook H., Zeng W., Chen G., Young N.S., and Maciejewski J.P. Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry. Blood 100 (2002) 178-183
27. Karadimitris A., Manavalan J.S., Thaler H.T., et al. Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood 96 (2000) 2613-2620
28. Wlodarski M.W., O'Keefe C., Howe E.C., et al. Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood 106 (2005) 2769-2780
29. Raza A. Hypothesis: myelodysplastic syndromes may have a viral etiology. Int J Hematol 68 (1998) 245-256
30. Maciejewski J.P., O'Keefe C., Gondek L., and Tiu R. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones. Folia Histochem Cytobiol 45 (2007) 5-14
31. Chamuleau M.E.D., Westers T.M., van Dreunen L., et al. Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome. Haematologica 94 (2009) 496-506
32. Moretti S., Lanza F., Spisani S., et al. Neutrophils from patients with myelodysplastic syndromes: relationship between impairment of granular contents, complement receptors, functional activities and disease status. Leuk Lymphoma 13 (1994) 471-477
33. Epling-Burnette P.K., Bai F., Painter J.S., et al. Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood 109 (2007) 4816-4824
34. Kiladjian J.J., Visentin G., Viey E., et al. Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes. Haematologica 93 (2008) 381-389